Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4, covering 2025-02-07 to 2025-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis [Phase 1]

See pricing